CRISPR Therapeutics
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
Business
Price matters. That’s true whether we’re talking about cars, houses, laptops, or anything else — including stocks. Three Motley Fool contributors had ...
2 Top Growth Stocks to Buy With $1,000 Right Now
Business
The healthcare industry has proved to be a remarkably resilient place for investors. Generally speaking, the kinds of products and services that ...
What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?
Business
CRISPR Therapeutics (NASDAQ: CRSP) has put itself on the map of the healthcare industry as a serious player in gene editing. Now ...
US approves two gene therapies for sickle cell disease
Science
By Leroy Leo (Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved a pair of gene therapies for sickle cell ...
UK becomes 1st country to approve gene therapy treatment for sickle cell, thalassemia
Science
LONDON (AP) — Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that ...
US FDA advisers to determine need for more studies of Vertex/CRISPR gene therapy
Science
By Sriparna Roy (Reuters) -The U.S. Food and Drug Administration’s staff reviewers on Friday asked the regulator’s advisory panel to consider the ...
A new cure for sickle cell disease may be coming. Health advisers will review it next week
Science
The only cure for painful sickle cell disease today is a bone marrow transplant. But soon there may be a new cure ...
